Milder is better? advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Revelli, Alberto ^a   Casano, Simona ^a   Salvagno, Francesca ^a   Delle Piane, Luisa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CETRORELIX; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; DRUG DERIVATIVE; GONADORELIN;

CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG CHOICE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG RESPONSE; EMOTIONAL STRESS; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE COST; HUMAN; LOW DRUG DOSE; OVARIAN RESERVE; OVULATION INDUCTION; REVIEW; DRUG ANTAGONISM; DRUG POTENTIATION; FOLLICULAR PHASE; METHODOLOGY; OVARY FOLLICLE; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIPTORELIN;

EID: 79951551613     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-25     Document Type: Review

References (59)

1. Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The Science behind 25 years of Ovarian Stimulation for In Vitro Fertilization. Endocr Rev 2006, 27(2):170-207. 10.1210/er.2005-0015, 16434510.
2. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000, 21(2):200-214. 10.1210/er.21.2.200, 10782364.
3. Fauser BCJM, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997, 18(1):71-106. 10.1210/er.18.1.71, 9034787.
4. Hohmann FP, Laven JSE, de Jong FH, Eijkemans MJ, Fauser BCJ. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod 2001, 16(5):846-854. 10.1093/humrep/16.5.846, 11331627.
5. Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC, Macklon NS. Contemporary pharmacogical manipulation in assisted reproduction. Drugs 2004, 64(3):297-322. 10.2165/00003495-200464030-00005, 14871171.
6. Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF?. Hum Reprod 2007, 22(11):2805-2813. 10.1093/humrep/dem270, 17872909.
7. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitisation in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev 2000, CD001299.
8. Ubaldi F, Rienzi L, Baroni E, Ferrero S Iacobelli M, Minasi MG, Sapienza F, Romano S, Colasant A, Litwicka K, Greco E. Hopes and facts about mild ovarian stimulation. Reprod BioMed Online 2007, 14(6):675-681. 10.1016/S1472-6483(10)60667-0, 17579976.
9. Macklon NS, Fauser BCJM. Mild stimulation in in vitro fertilization. Ann N Y Acad Sci 2003, 997:105-111. 10.1196/annals.1290.012, 14644815.
10. Nargund J, Fauser BCJM, Macklon NS, Ombelet W, Nygren K, Frydman R. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 2007, 11(14):2801-2504.
11. Fernandez-Shaw S, Pèrez Esturo N, Cercas Dunque R, Pons Mallol I. Mild IVF using GNRH agonist long protocol is possible: comparing stimulations with 100 UI vs. 150 UI recombinant FSH at starting dose. J Assist Reprod Genet 2009, 26(2-3):75-82. 10.1007/s10815-008-9289-z, 2654940, 19151931.
12. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane Review. Hum Reprod 2002, 17(4):874-885. 10.1093/humrep/17.4.874, 11925376.
13. Hayden C. GnRH analogues: applications in assisted reproductive techniques. Eur J Endocrinol 2008, 159(1):17-25.
14. Griesinger G, Felberbaum R, Diedrich K. GnRH antagonist in ovarian stimulation: a treatment regimen of clinicians' second choise? Data from the Germany national IVF registry. Hum Reprod 2005, 20(9):2373-2375. 10.1093/humrep/dei086, 15932915.
15. Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K. GnRH agonist and antagonist in assisted reproduction: pregnancy rate. Reprod BioMed Online 2006, 13(1):84-87. 10.1016/S1472-6483(10)62019-6, 16820115.
16. Kolibianakis EM, Collins I, Tarlatzis BC, Devroey P, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006, 12a(6):651-671.
17. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006, 19(3):CD001750.
18. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropine-releasing hormone (GnRH) antagonist co-treatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 2003, 88(1):166-173. 10.1210/jc.2002-020788, 12519847.
19. van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, Fauser BC, Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006, 13(4):476-480. 10.1016/S1472-6483(10)60633-5, 17007663.
20. Verberg MFG, Eijkemans MJC, Macklon NS, Heijen EMEW, Baart EB, Hohmann FP, Fauser BCJM, Broekmans FJ. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update 2009, 15(1):5-12. 10.1093/humupd/dmn053, 19091754.
21. Hejinen EMEW, Eijkemans MJC, De Klerk C, Polinder S, Beckers NGM, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BCJM. A mild treatment strategy for in vitro fertilization: a randomised non inferiority trial. The Lancet 2007, 369(9563):743-749.
22. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ. Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril 2008, 89(5):1159-1165. 10.1016/j.fertnstert.2007.05.020, 17686477.
23. Baart EB, Martini E, Eijkemans MJ, Van Ostal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder Ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomised controlled trial. Hum Reprod 2007, 22(4):980-988. 10.1093/humrep/del484, 17204525.
24. Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod 2001, 16(2):221-225. 10.1093/humrep/16.2.221, 11157810.
25. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans F. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod 2007, 22(7):1919-1924. 10.1093/humrep/dem089, 17485438.
26. Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, Pellicer A, Simón C. Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab 2008, 93(11):4500-4510. 10.1210/jc.2008-0588, 18697870.
27. Horcajadas JA, Díaz-Gimeno P, Pellicer A, Simón C. Uterine receptivity and the ramifications of ovarian stimulation on endometrial function. Semin Reprod Med 2007, 25(6):454-460. 10.1055/s-2007-991043, 17960530.
28. Martínez-Conejero JA, Simón C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium?. Reprod Biomed Online 2007, 15(1):45-50.
29. Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod 1999, 14(2):107-11.
30. Check JH, Choe JK, Nazari A, Summers-Chase D. Ovarian hyperstimulation can reduce uterine receptivity. A case report. Clin Exp Obstet Gynecol 2000, 27(2):89-91.
31. Check JH, Check ML. A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation. Clin Exp Obstet Gynecol 2001, 28(4):217-218.
32. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2009, 91(3):749-766. 10.1016/j.fertnstert.2007.12.077, 18639875.
33. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, Mc Tavish AR. Interventions for " poor responders" to controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF). Cochrane Database Syst Rev 2007, 24(1):CD004379.
34. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003, 9(1):61-76. 10.1093/humupd/dmg007, 12638782.
35. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996, 65(5):961-965.
36. Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet 2008, 25(11):515-521. 10.1007/s10815-008-9266-6, 2593769, 18972201.
37. Pantois C, Thotnton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotropine dose- does the response really improve?. Fertil Steril 1990, 53(3):436-439.
38. Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril 2008, 89(6):1694-1701. 10.1016/j.fertnstert.2007.05.055, 2601677, 18440515.
39. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996, 17(2):121-155.
40. Check JH. Mild ovarian stimulation. J Assist Reprod Genet 2007, 24(12):621-627. 10.1007/s10815-007-9179-9, 18058016.
41. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril 2007, 87(4):749-756. 10.1016/j.fertnstert.2006.11.001, 17207795.
42. Adashi EY. Clomiphene Citrate: mechanisms and sites of action- a hypothesis revisited. Fertil Steril 1984, 42(3):331-343.
43. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH protocols?. Hum Reprod 1999, 14(12):2959-2962. 10.1093/humrep/14.12.2959, 10601078.
44. Takahashi K, Mukaida T, Tomiyana T, Goto T, Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet 2004, 21(9):317-322. 10.1023/B:JARG.0000045470.68525.a4, 15587144.
45. D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM. A novel protocol of ovulation induction with delayed gonadotrophin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 2004, 81(6):1572-1577.
46. Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet 2010, 281(4):741-746. 10.1007/s00404-009-1252-4, 19834718.
47. Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropine/cetrorelix protocol and buserelin long protocol- a randomized study. Gynecol Endocrinol 2006, 22(6):297-302. 10.1080/09513590600702733, 16785154.
48. Williams SC, Gibbons WE, Muasher SJ, Oehninger S. Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropine with or without the addition of a gonadotropine-releasing hormone antagonist. Fertil Steril 2002, 78(5):1068-1072. 10.1016/S0015-0282(02)03374-5, 12413995.
49. Yanaihara A, Yorimitsu T, Motoyama H, Ohara M, Kawamura T. The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome. J Assist Reprod Genet 2008, 25(4):115-118. 10.1007/s10815-008-9205-6, 2582073, 18368475.
50. Fauser BCJM, Devroey P, Yen SSC, Gosden R, Crowley WC, Baird DT, Bouchard P. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 1999, 14(11):2681-2686. 10.1093/humrep/14.11.2681, 10548600.
51. Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod 2009, 24(10):2389-2394. 10.1093/humrep/dep246, 19608565.
52. Bristow RE, Karlan BY. Ovulation induction, infertility and ovarian cancer risk. Fertil Steril 1996, 66(4):499-507.
53. Shoham Z. Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma. Where are we today?. Fertil Steril 1994, 62(3):433-448.
54. de Klerk C, Heijnen EM, Macklon NS, Duivenvoorden HJ, Fauser BC, Passchier J, Hunfeld JA. The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod 2006, 21(3):721-727. 10.1093/humrep/dei395, 16311295.
55. Slade P, Emery J, Lieberman BA. A prospective, longitudinal study of emotions and relationships in in vitro fertilization treatment. Hum Reprod 1997, 12(1):183-190. 10.1093/humrep/12.1.183, 9043926.
56. De Klerk C, Macklon NS, Hejinen EMEW, Eijkemans MJC, Fauser BCJM, Passchier J, Hunfeld JAM. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod 2007, 22(9):2554-2558. 10.1093/humrep/dem171, 17586832.
57. Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod 1999, 14(2):107-11.
58. Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod 2009, 24(4):764-774. 10.1093/humrep/den468, 19153090.
59. Polinder S, Heijnen EMEW, Macklon NS, Habbema JDF, Fauser BJCM, Eijemans MJC. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod 2008, 23(2):316-323. 10.1093/humrep/dem372, 18033807.